Skip to content

Peritoneal Cavity Conditioning During Open Surgery.

Peritoneal Cavity Conditioning During Open Surgery Decreases Postoperative Pain and Inflammation and Decreases Time to Restore Transit

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01098175
Enrollment
40
Registered
2010-04-02
Start date
2010-04-30
Completion date
2011-12-31
Last updated
2010-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparotomy, Thoracotomy

Keywords

laparotomy, thoracotomy, peritoneal conditioning, humidification, temperature control

Brief summary

Given the observations in animal models and the available data in the human our hypothesis is that peritoneal cavity conditioning (carbon dioxide with 4% of oxygen and 10% of N2O, 100% humidification at 32°C,) during open surgery, will result in an important decrease in postoperative peritoneal inflammation, postoperative pain, and will restore bowel transit faster.

Detailed description

Aim of the Trial : RCT demonstrating that peritoneal cavity conditioning during open surgery will result in a less postoperative inflammation, less postoperative pain, and shorter time to flatus and transit.

Interventions

None listed

Sponsors

KU Leuven
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

: * patients will be stratified and randomised according to the type of surgery * total laparoscopic hysterectomy, * promontofixation * cholecystectomy

Exclusion criteria

: * Any pre-existing condition increasing the risk of surgery such as age, pre-existing conditions as clotting disorders, heart or lung impairment etc. * Not signed informed consent * known allergic reaction to Sprayshield, Intercoat of hyalobarrier gel ® or - any bowel lesion requiring a single or double layer suture. (given that for none of the any anti-adhesion barriers safety has been proven following bowel lesions and suture) * Any condition that might interfere with inflammatory parameters or pre-existing such as ,pregnancy, immunodeficiency, chronic inflammatory disease as Crohn's disease, chronic pain conditions as (peripheral neuropathy, pathology of the vertebral column and osteo-articular disease, any condition causing acute pain e.g. trauma.

Design outcomes

Primary

MeasureTime frameDescription
Primary endpoint : decreased pain on day 1 and 2 after surgery0 to 7 daysPostoperative pain : will be assessed by visual analog scales (cfr Trial by Verguts & Koninckx, addendum I) assessed pain on day 1, 2 and 3 after surgery. Pain medication will be free, but preferentially ibuprofen will be used in order to permit easier comparison of pain killer intake.

Secondary

MeasureTime frameDescription
decrease in CRP and inflammatory parameters on day 1 and 2 or longerday 1-4Postoperative inflammatory reaction : daily assessment of inflammatory parameters as CRP, leucocytosis , and temperature for 4 to 7 days are done routinely today. In some subsets of patients other more specific inflammatory parameters as Ca125, IL-6 can be investigated
lower peritoneal fluid volume on day 2day 2 after surgeryEstimation of peritoneal fluid volume by ultrasound on the second day after surgery will be performed in some subsets of patients. We indeed recently validated a non-invasive and reliable assessment of peritoneal fluid volume by ultrasound. (Verguts et all, 2009) We expect that the postoperative peritoneal fluid volume will increase with the degree of peritoneal inflammation.
Shorter time to resumption of transit: time to first flatus and time to first stoolday1 to 5Time to first flatus and time to first stool will be recorded

Countries

Belgium

Contacts

Primary ContactPhilippe R Koninckx, MD
pkoninckx@gmail.com+32 16 344202
Backup ContactMarleen Craessaerts, RN
mcraessaerts@gmail.com+32 16 343606

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026